Russell Investments Group, Ltd. Alnylam Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 42,324 shares of ALNY stock, worth $10.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
42,324
Previous 41,185 2.77%
Holding current value
$10.9 Million
Previous $10 Million 16.34%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$233.81 - $287.01 $266,309 - $326,904
1,139 Added 2.77%
42,324 $11.6 Million
Q2 2024

Aug 08, 2024
SELL
$143.31 - $247.0 $2.52 Million - $4.34 Million
-17,554 Reduced 29.88%
41,185 $10 Million
Q1 2024

May 08, 2024
BUY
$146.51 - $198.2 $4.05 Million - $5.48 Million
27,650 Added 88.94%
58,739 $8.78 Million
Q4 2023

Feb 05, 2024
BUY
$151.41 - $196.57 $1.05 Million - $1.37 Million
6,963 Added 28.86%
31,089 $5.95 Million
Q3 2023

Nov 13, 2023
SELL
$170.77 - $211.65 $585,228 - $725,324
-3,427 Reduced 12.44%
24,126 $4.27 Million
Q2 2023

Aug 10, 2023
SELL
$185.01 - $212.05 $100,830 - $115,567
-545 Reduced 1.94%
27,553 $5.23 Million
Q1 2023

May 09, 2023
SELL
$182.66 - $235.53 $1.46 Million - $1.88 Million
-8,001 Reduced 22.16%
28,098 $5.63 Million
Q4 2022

Feb 08, 2023
SELL
$185.53 - $241.31 $371,616 - $483,343
-2,003 Reduced 5.26%
36,099 $8.58 Million
Q3 2022

Nov 04, 2022
BUY
$138.54 - $232.0 $17,317 - $29,000
125 Added 0.33%
38,102 $7.87 Million
Q2 2022

Jul 29, 2022
SELL
$120.42 - $169.29 $242,164 - $340,442
-2,011 Reduced 5.03%
37,977 $5.53 Million
Q1 2022

May 05, 2022
SELL
$127.18 - $173.91 $4.54 Million - $6.21 Million
-35,680 Reduced 47.15%
39,988 $6.58 Million
Q4 2021

Jan 21, 2022
BUY
$159.56 - $209.29 $2.85 Million - $3.74 Million
17,891 Added 30.97%
75,668 $12.9 Million
Q3 2021

Nov 08, 2021
BUY
$169.75 - $207.73 $651,161 - $796,852
3,836 Added 7.11%
57,777 $10.6 Million
Q2 2021

Aug 04, 2021
SELL
$128.63 - $176.89 $420,491 - $578,253
-3,269 Reduced 5.71%
53,941 $9.05 Million
Q1 2021

May 10, 2021
SELL
$126.83 - $175.69 $155,113 - $214,868
-1,223 Reduced 2.09%
57,210 $7.91 Million
Q4 2020

Feb 08, 2021
SELL
$122.97 - $147.0 $555,824 - $664,440
-4,520 Reduced 7.18%
58,433 $7.62 Million
Q3 2020

Nov 09, 2020
SELL
$121.19 - $165.49 $1.27 Million - $1.74 Million
-10,491 Reduced 14.28%
62,953 $9.14 Million
Q2 2020

Aug 05, 2020
BUY
$104.21 - $156.44 $2.23 Million - $3.35 Million
21,423 Added 41.18%
73,444 $10.9 Million
Q1 2020

May 06, 2020
BUY
$93.12 - $133.99 $557,788 - $802,600
5,990 Added 13.01%
52,021 $5.66 Million
Q4 2019

Jan 29, 2020
SELL
$74.51 - $124.23 $407,495 - $679,413
-5,469 Reduced 10.62%
46,031 $5.28 Million
Q3 2019

Nov 01, 2019
BUY
$70.9 - $87.82 $1.39 Million - $1.72 Million
19,641 Added 61.65%
51,500 $4.18 Million
Q2 2019

Aug 09, 2019
SELL
$65.86 - $92.79 $450,877 - $635,240
-6,846 Reduced 17.69%
31,859 $2.27 Million
Q1 2019

May 13, 2019
BUY
$72.76 - $93.45 $1.11 Million - $1.43 Million
15,251 Added 65.03%
38,705 $3.53 Million
Q4 2018

Feb 11, 2019
SELL
$62.67 - $88.33 $239,712 - $337,862
-3,825 Reduced 14.02%
23,454 $1.65 Million
Q2 2018

Aug 08, 2018
SELL
$88.31 - $107.8 $1.95 Million - $2.39 Million
-22,131 Reduced 44.79%
27,279 $2.65 Million
Q1 2018

May 11, 2018
BUY
$115.92 - $148.54 $467,621 - $599,210
4,034 Added 8.89%
49,410 $5.89 Million
Q4 2017

Feb 06, 2018
SELL
$114.49 - $139.98 $1.01 Million - $1.24 Million
-8,863 Reduced 16.34%
45,376 $5.89 Million
Q3 2017

Nov 07, 2017
BUY
$72.53 - $118.27 $3.93 Million - $6.41 Million
54,239
54,239 $6.37 Million

Others Institutions Holding ALNY

# of Institutions
639
Shares Held
108M
Call Options Held
1.15M
Put Options Held
1.07M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.7B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email